112 related articles for article (PubMed ID: 3933828)
21. Impacts of chemicals on liver cancer risk.
Wogan GN
Semin Cancer Biol; 2000 Jun; 10(3):201-10. PubMed ID: 10936069
[TBL] [Abstract][Full Text] [Related]
22. Effect of steroids on drug metabolism in male and female rats.
Stripp B; Menard RH; Zampaglione NG; Hamrick ME; Gillette JR
Drug Metab Dispos; 1973; 1(1):216-23. PubMed ID: 4149385
[No Abstract] [Full Text] [Related]
23. [Metabolism of drugs. II. The factors influencing metabolic reactions].
Dyderski S; Grzymisławski M
Pol Merkur Lekarski; 2005 Apr; 18(106):453-6. PubMed ID: 16161933
[TBL] [Abstract][Full Text] [Related]
24. Interindividual differences in drug oxidation: clinical importance.
Sjöqvist F; von Bahr C
Drug Metab Dispos; 1973; 1(1):469-82. PubMed ID: 4149420
[No Abstract] [Full Text] [Related]
25. Health-related disparities: influence of environmental factors.
Olden K; White SL
Med Clin North Am; 2005 Jul; 89(4):721-38. PubMed ID: 15925646
[TBL] [Abstract][Full Text] [Related]
26. Nutrient interaction with drugs and other xenobiotics.
Hayes JR; Borzelleca JF
J Am Diet Assoc; 1985 Mar; 85(3):335-9. PubMed ID: 3973324
[TBL] [Abstract][Full Text] [Related]
27. Interindividual differences in rates of drug oxidation in man.
Davies DS; Thorgeirsson SS; Breckenridge A; Orme M
Drug Metab Dispos; 1973; 1(1):411-7. PubMed ID: 4149412
[No Abstract] [Full Text] [Related]
28. Dietary modification of aflatoxin B1 carcinogenesis: mechanism studies with isolated hepatocytes from rainbow trout.
Bailey GS; Taylor MJ; Loveland PM; Wilcox JS; Sinnhuber RO; Selivonchick DP
Natl Cancer Inst Monogr; 1984 May; 65():379-85. PubMed ID: 6431290
[TBL] [Abstract][Full Text] [Related]
29. Activation and inhibition of benzo(a)pyrene and aflatoxin B1 metabolism in human liver microsomes by naturally occurring flavonoids.
Buening MK; Chang RL; Huang MT; Fortner JG; Wood AW; Conney AH
Cancer Res; 1981 Jan; 41(1):67-72. PubMed ID: 7448777
[TBL] [Abstract][Full Text] [Related]
30. Research review. Interactions between environmental chemicals and drug biotransformation in man.
Alvares AP
Clin Pharmacokinet; 1978; 3(6):462-77. PubMed ID: 214266
[TBL] [Abstract][Full Text] [Related]
31. Contributions of two inducible forms of cytochrome P-450 in rat liver microsomes to the metabolic activation of various chemical carcinogens.
Kawajiri K; Yonekawa H; Gotoh O; Watanabe J; Igarashi S; Tagashira Y
Cancer Res; 1983 Feb; 43(2):819-23. PubMed ID: 6401224
[No Abstract] [Full Text] [Related]
32. [Effect of environmental chemical agents on drug metabolism in man].
Puzyńska L
Pol Tyg Lek; 1980 Apr; 35(14):509-12. PubMed ID: 6773039
[No Abstract] [Full Text] [Related]
33. Evaluation of chemiluminescence generation during microsomal metabolism of some carcinogens.
Emerole GO; Dixon RL
Cancer Res; 1980 Jun; 40(6):2002-5. PubMed ID: 6768456
[No Abstract] [Full Text] [Related]
34. Food and drug interactions.
Carr CJ
Annu Rev Pharmacol Toxicol; 1982; 22():19-29. PubMed ID: 6282186
[TBL] [Abstract][Full Text] [Related]
35. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention.
Buetler TM; Bammler TK; Hayes JD; Eaton DL
Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305
[TBL] [Abstract][Full Text] [Related]
36. Metabolism of xenobiotics and chemical carcinogenesis.
Lang M; Pelkonen O
IARC Sci Publ; 1999; (148):13-22. PubMed ID: 10493245
[TBL] [Abstract][Full Text] [Related]
37. Use of the isolated perfused rat liver to study carcinogen-DNA adduct formation from aflatoxin B1 and sterigmatocystin.
Essigmann JM; Donahue PR; Story DL; Wogan GN; Brunengraber H
Cancer Res; 1980 Nov; 40(11):4085-91. PubMed ID: 6781740
[No Abstract] [Full Text] [Related]
38. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts.
Yu MW; Lien JP; Liaw YF; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):613-9. PubMed ID: 8824363
[TBL] [Abstract][Full Text] [Related]
39. Interindividual variance of cytochrome P450 forms in human hepatic microsomes: correlation of individual forms with xenobiotic metabolism and implications in risk assessment.
Snawder JE; Lipscomb JC
Regul Toxicol Pharmacol; 2000 Oct; 32(2):200-9. PubMed ID: 11067776
[TBL] [Abstract][Full Text] [Related]
40. The effect of spironolactone on drug metabolism by hepatic microsomes.
Stripp B; Hamrick ME; Zampaglione NG; Gillette JR
J Pharmacol Exp Ther; 1971 Mar; 176(3):766-71. PubMed ID: 5111461
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
